[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604259":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":39,"locations":45,"responsibleParty":89,"collaborators":25,"id":91,"slug":92,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":95,"acronym":25,"eligibilityCriteria":96,"healthyVolunteers":93,"sex":97,"minAge":98,"maxAge":25,"enrollmentInfo":99,"targetDuration":25,"studyType":102,"phases":103,"briefSummary":105,"conditions":106,"keywords":108,"overallStatus":48,"whyStopped":25,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"Alcon Research","INDUSTRY",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"AAL-FAIOL","EXPERIMENTAL","The clouded lens will be removed by phacoemulsification, after which the AAL-FAIOL will be implanted in one eye.",[13,14],"Device: AAL-FAIOL","Procedure: Phacoemulsification",{"label":16,"type":10,"description":17,"interventionNames":18},"BAL-FAIOL","The clouded lens will be removed by phacoemulsification, after which the BAL-FAIOL will be implanted in one eye.",[19,14],"Device: BAL-FAIOL",[21,26,29],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Intraocular lens (IOL) placed into the lens capsule of the eye during cataract surgery. IOLs are implantable medical devices intended for long-term use over the lifetime of the pseudophakic subject. Laser energy to specified locations can be used to allow a change in power for far distances.",[9],null,{"type":22,"name":16,"description":27,"armGroupLabels":28,"otherNames":25},"Intraocular lens (IOL) placed into the lens capsule of the eye during cataract surgery. IOLs are implantable medical devices intended for long-term use over the lifetime of the pseudophakic subject.",[16],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":25},"PROCEDURE","Phacoemulsification","Cataract surgery technique that uses ultrasound to break up and remove the clouded lens, allowing for intraocular lens (IOL) implantation.",[9,16],[35],{"name":36,"affiliation":37,"role":38},"Clinical Trial Lead, Surgical","Alcon Research, LLC","STUDY_DIRECTOR",[40],{"name":41,"role":42,"phone":43,"phoneExt":25,"email":44},"Alcon Call Center","CONTACT","1-888-451-3937","alcon.medinfo@alcon.com",[46,58,69,79],{"facility":47,"status":48,"city":49,"state":25,"zip":25,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":25},"Clinica 20\u002F20","RECRUITING","San José","Costa Rica","CR",{"type":53,"coordinates":54},"Point",[55,56],-84.08489,9.93388,{"lat":56,"lon":55},{"facility":59,"status":60,"city":61,"state":25,"zip":25,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":68,"contacts":25},"Instituto Espaillat Cabral","NOT_YET_RECRUITING","Santo Domingo","Dominican Republic","DO",{"type":53,"coordinates":65},[66,67],-69.89232,18.47186,{"lat":67,"lon":66},{"facility":70,"status":60,"city":71,"state":25,"zip":25,"country":72,"countryCode":73,"cosmosGeoPoint":74,"geoPoint":78,"contacts":25},"Centro Panamericano de Ojos \u002F Clinica Lopez Beltran","San Salvador","El Salvador","SV",{"type":53,"coordinates":75},[76,77],-89.18718,13.68935,{"lat":77,"lon":76},{"facility":80,"status":48,"city":81,"state":25,"zip":25,"country":82,"countryCode":83,"cosmosGeoPoint":84,"geoPoint":88,"contacts":25},"Panama Eye Center","Panama City","Panama","PA",{"type":53,"coordinates":85},[86,87],-79.51973,8.9936,{"lat":87,"lon":86},{"type":90,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100604259","feasibility-study-of-an-accommodating-iol-design-100604259",false,"NCT07147192","Feasibility Study of an Accommodating IOL Design","Key Inclusion Criteria:\n\n* Able to understand and sign an Informed Consent Form.\n* Willing and able to attend all scheduled study visits required per protocol.\n* Diagnosed with bilateral cataracts requiring removal by phacoemulsification.\n* Preoperative corneal astigmatism equal to or less than 1.50 diopter (D) in both eyes.\n* Other protocol-defined inclusion criteria may apply.\n\nKey Exclusion Criteria:\n\n* Women of childbearing potential who are pregnant, intend to become pregnant during the study, or are breastfeeding.\n* Taking medications that could increase risk or may affect accommodation.\n* Eye conditions as specified in the protocol, including glaucoma or ocular hypertension.\n* Medical conditions that could increase operative risk as specified in the protocol.\n* Other protocol-defined exclusion criteria may apply.","ALL","22 Years",{"count":100,"type":101},85,"ESTIMATED","INTERVENTIONAL",[104],"NA","The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.",[107],"Aphakia",[109],"Cataract","2026-05-18",{"date":112,"type":113},"2026-05-19","ACTUAL",{"date":115,"type":113},"2025-12-03",{"date":117,"type":101},"2028-01",{"name":5,"class":6},4]